Seeing Is Believing
PCSA is currently covered by 4 analysts with an average price target of $22.91. This is a potential upside of $22.05 (2563.95%) from yesterday's end of day stock price of $0.86.
Processa Pharmaceuticals's activity chart (see below) currently has 3 price targets and 13 ratings on display. The stock rating distribution of PCSA is 90% BUY and 10% HOLD.
Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 160.75 days.
Highest price target for PCSA is $6, Lowest price target is $6, average price target is $22.91.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 03-Oct-2024. First documented stock forecast 08-Dec-2020.
Currently out of the existing stock ratings of PCSA, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$6
$4.99 (494.06%)
$6
1 months 20 days ago
(03-Oct-2024)
0/6 (0%)
$4.69 (358.02%)
Hold
$180
1 years 6 days ago
(17-Nov-2023)
0/1 (0%)
$117.4 (187.54%)
Buy
$9
1 years 7 months 19 days ago
(04-Apr-2023)
1/2 (50%)
$-27.2 (-75.14%)
307
Buy
$3
$0.76 (33.93%)
$17
1 years 7 months 20 days ago
(03-Apr-2023)
2/2 (100%)
$-6.7 (-69.07%)
336
What is PCSA (Processa Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most bullish on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most reserved on PCSA (Processa Pharmaceuticals)?